Data comparing outcomes of transradial (TR) versus transfemoral (TF) access for percutaneous
coronary intervention (PCI) in chronic kidney disease (CKD) including patients with
eGFR< 30 ml/min/1.73m2 and patients with end-stage renal disease on dialysis (ESRD) are lacking. This meta-analysis
compares the outcomes of TR versus TF approach for PCI in patients with CKD. PubMed,
Embase, Cochrane, ClinicalTrials.gov, and Google Scholar were searched for studies
including adults with CKD undergoing PCI via a TR versus TF approach from January
1, 2000, until January 15, 2021. The primary outcome was in-hospital all-cause mortality
and secondary outcomes included major bleeding, stroke, myocardial infarction (MI),
blood transfusion, contrast volume, and fluoroscopy time. The analysis was performed
using a random-effects-model using the Mantel‐Haenszel method. Five observational
studies met inclusion criteria, including 1,156 and 6,156 patients in the TR and TF
arms, respectively. The mean age of included patients was 70.5 years, 66% were male
and 90% had ESRD. In patients with CKD, TR access for PCI was associated with lower
all-cause mortality (RR = 0.48; 95% CI: 0.32 to 0.73), major bleeding (RR = 0.51;
95% CI: 0.36 to 0.73), blood transfusion (RR = 0.53, 95% CI: 0.42 to 0.68) and contrast
volume (SMD -0.34 [-0.60 to -0.08]) with no difference in stroke, MI, or fluoroscopy
time compared with TF access. In conclusion, in patients with CKD undergoing PCI,
the TR approach was associated with a lower risk of in-hospital mortality, post-procedural
bleeding, and blood transfusion compared with TF access.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Percutaneous coronary intervention and inpatient mortality in patients with advanced chronic kidney disease presenting with acute coronary syndrome.Proc (Bayl Univ Med Cent). 2017; 30: 400-403
- Comparative efficacy of transradial versus transfemoral approach for coronary angiography and percutaneous coronary intervention.Am J Cardiol. 2016; 118: 482-488
- Association between maximal activated clotting time and major bleeding complications during transradial and transfemoral percutaneous coronary intervention.JACC Cardiovasc Interv. 2018; 11: 1036-1045
- Transradial versus transfemoral approach for coronary angiography and angioplasty–a prospective, randomized comparison.BMC cardiovasc Disord. 2017; 17: 1-7
- Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: a study of the Italian Radial Club.Catheter Cardiovasc Interv. 2018; 91: 97-102
- Meta-analysis of transradial vs transfemoral access for percutaneous coronary intervention in patients with ST elevation myocardial infarction.Am J Cardiol. 2021; 141: 23-30
- Clinical practice guidelines for vascular access.Am J Kidney Dis. 2006; 48: S176-S247
- Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention: an opportunity for quality improvement.J Am Heart Assoc. 2012; (A14773): A14773
- Radial artery occlusion after transradial interventions: a systematic review and meta-analysis.J Am Heart Assoc. 2016; 5e002686
- US renal data system 2017 annual data report: epidemiology of kidney disease in the United States.Am J Kidney Dis. 2018; 71: A7
- Radial artery occlusion after transradial coronary catheterization.Cardiovasc Diagn Ther. 2017; 7: 305-316
- Trans-radial percutaneous coronary intervention for patients with severe chronic renal insufficiency and/or on dialysis.Heart Vessels. 2019; 34: 1412-1419
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.Ann Intern Med. 2009; 151 (264-9): w64
- Radial access use for percutaneous coronary intervention in dialysis patients.Circ Cardiovasc Interv. 2020; 13e008418
- Outcomes of transradial approach to percutaneous coronary intervention in end-stage renal disease patients on dialysis.Cardiovasc Revasc Med. 2020; 21: 1131-1135
- Transradial percutaneous coronary intervention in patients with advanced chronic kidney disease.Cardiovasc Revasc Med. 2020; 21: 1138-1143
- Forearm versus femoral approach for cardiac catheterization in end-stage renal disease patients.J Invasive Cardiol. 2018; 30: 110-114
- Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.JACC Cardiovasc Interv. 2013; 6: 814-823
- Association of hemoglobin levels with clinical outcomes in acute coronary syndromes.Circ. 2005; 111: 2042-2049
- The implications of blood transfusions for patients with non–ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative.J Am Coll Cardiol. 2005; 46: 1490-1495
- Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.JAMA. 2004; 292: 1555-1562
- Markers of inflammation and their changes over time in relationship to clinical outcomes and therapeutic interventions in the acute coronary syndrome patient: results from the ACUITY inflammation sub-study.J Am Cardiol. 2006; 98 (36M): 36M
- ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial.J Am Coll Cardiol. 2014; 63: 964-972
- Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.Lancet. 2011; 377: 1409-1420
- Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.Lancet. 2018; 392: 835-848
- Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study.J Am Coll Cardiol. 2012; 60: 2481-2489
- Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial.J Am Cardiol. 2007; 100: 1364-1369
- An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry.JACC Cardiovasc Inter. 2013; 6: 897-904
- Best practices for the prevention of radial artery occlusion after transradial diagnostic angiography and intervention: an international consensus paper.JACC Cardiovasc Interv. 2019; 12: 2235-2246
- Meta-analysis of stroke after transradial versus transfemoral artery catheterization.Int J Cardiol. 2013; 168: 5234-5238
- Influence of access site choice for cardiac catheterization on risk of adverse neurological events: a systematic review and meta-analysis.Am Heart J. 2016; 181: 107-119
Article info
Publication history
Published online: August 11, 2021
Received in revised form:
July 2,
2021
Received:
May 24,
2021
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
